Literature DB >> 34598105

Emotional and stigma-related experiences relative to being told one is at risk for psychosis.

Kristen A Woodberry1, Kate S Powers2, Caitlin Bryant3, Donna Downing2, Mary B Verdi2, Katherine M Elacqua2, Audrey R L Reuman4, Leda Kennedy5, Daniel I Shapiro6, Michelle L West7, Debbie Huang8, Francesca M Crump9, Margaux M Grivel10, Drew Blasco10, Shaynna N Herrera11, Cheryl M Corcoran12, Larry J Seidman13, Bruce G Link14, William R McFarlane15, Lawrence H Yang16.   

Abstract

OBJECTIVE: Despite the appeal of early intervention in psychosis, there is concern that identifying youth as having high psychosis risk (PR) may trigger stigma. This study employed a pre-post design to measure change in PR participants' emotions about PR upon being told of their PR status and according to whether this was the first time receiving this information.
METHODS: Participants (n = 54) identified as at PR via structured interview rated their emotions about PR before and after being told they were at PR. Qualitative analyses explored the valence of participant reflections on being given this information.
RESULTS: Participants reported significantly less negative emotion after being told of their PR status (p < .001), regardless of whether they were hearing this for the first time (p = .72). There was no change in positive emotions or the predominant belief that they should keep their PR status private. Most participants commented positively about the process of feedback but negatively about its impact on their self-perceptions and/or expectations of others' perceptions of them.
CONCLUSION: This is the first study to collect pre-post data related to being told one is at PR and to examine quantitative and qualitative responses across and within individuals. For a majority of participants, clinical feedback stimulated negative stereotypes even as it relieved some distress. To actively address internalized stigma, clinicians providing feedback to PR youth must attend to the positive and negative impacts on how youth think about themselves as well as how they feel.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Clinical high risk; Feedback; Labeling; Pre-post; Prodrome

Mesh:

Year:  2021        PMID: 34598105      PMCID: PMC8633064          DOI: 10.1016/j.schres.2021.09.017

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.662


  21 in total

1.  Stigma as a stressor and transition to schizophrenia after one year among young people at risk of psychosis.

Authors:  Nicolas Rüsch; Karsten Heekeren; Anastasia Theodoridou; Mario Müller; Patrick W Corrigan; Benjamin Mayer; Sibylle Metzler; Diane Dvorsky; Susanne Walitza; Wulf Rössler
Journal:  Schizophr Res       Date:  2015-05-31       Impact factor: 4.939

2.  Psychosis Risk: What Is It and How Should We Talk About It?

Authors:  Dominic A Sisti; Monica E Calkins
Journal:  AMA J Ethics       Date:  2016-06-01

Review 3.  Ethical, Legal, and Clinical Considerations when Disclosing a High-Risk Syndrome for Psychosis.

Authors:  Vijay A Mittal; Derek J Dean; Jyoti Mittal; Elyn R Saks
Journal:  Bioethics       Date:  2015-02-17       Impact factor: 1.898

4.  Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort.

Authors:  Kristen A Woodberry; Larry J Seidman; Caitlin Bryant; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Daniel H Mathalon; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods
Journal:  J Clin Child Adolesc Psychol       Date:  2016-10-05

5.  Impact of "psychosis risk" identification: Examining predictors of how youth view themselves.

Authors:  Lawrence H Yang; Kristen A Woodberry; Bruce G Link; Cheryl M Corcoran; Caitlin Bryant; Daniel I Shapiro; Donna Downing; Ragy R Girgis; Gary Brucato; Debbie Huang; Francesca M Crump; Mary Verdi; William R McFarlane; Larry J Seidman
Journal:  Schizophr Res       Date:  2019-02-19       Impact factor: 4.939

6.  Observations of a small sample of adolescents experiencing an at-risk mental state (ARMS) for psychosis.

Authors:  Patrick Welsh; Paul A Tiffin
Journal:  Schizophr Bull       Date:  2011-10-20       Impact factor: 9.306

7.  Should we be concerned about stigma and discrimination in people at risk for psychosis? A systematic review.

Authors:  Marco Colizzi; Mirella Ruggeri; Antonio Lasalvia
Journal:  Psychol Med       Date:  2020-02-17       Impact factor: 7.723

Review 8.  Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Authors:  Kristen A Woodberry; Daniel I Shapiro; Caitlin Bryant; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

9.  Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia.

Authors:  Barbara A Cornblatt; Andrea M Auther; Tara Niendam; Christopher W Smith; Jamie Zinberg; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2007-04-17       Impact factor: 9.306

10.  Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial.

Authors:  Mark van der Gaag; Dorien H Nieman; Judith Rietdijk; Sara Dragt; Helga K Ising; Rianne M C Klaassen; Maarten Koeter; Pim Cuijpers; Lex Wunderink; Don H Linszen
Journal:  Schizophr Bull       Date:  2012-09-01       Impact factor: 9.306

View more
  2 in total

1.  Screening for Early Emerging Mental Experiences (SEE ME): A Model to Improve Early Detection of Psychosis in Integrated Primary Care.

Authors:  Kristen A Woodberry; Kelsey A Johnson; Lydia A Shrier
Journal:  Front Pediatr       Date:  2022-06-10       Impact factor: 3.569

2.  Application of the unified protocol for the transdiagnostic treatment of comorbid emotional disorders in patients with ultra-high risk of developing psychosis: A randomized trial study protocol.

Authors:  Trinidad Peláez; Raquel López-Carrillero; Marta Ferrer-Quintero; Susana Ochoa; Jorge Osma
Journal:  Front Psychol       Date:  2022-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.